Cancer Research Translational Cancer Medicine 2008: Cancer Clinical Trials and Personalized Medicine  Susan G. Komen for the Cure-AACR Outstanding Investigator Award for Breast Cancer Research
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Cell Growth & Differentiation

[Cancer Research 26, 1971-1979, September 1, 1966]
© 1966 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Herriott, R. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Herriott, R. M.

Mutagenesis

Roger M. Herriott

The Johns Hopkins University, Baltimore, Maryland

It is now generally accepted that the simplest mutation involves a change in a single base of DNA, so a different amino acid is coded. The new amino acid alters the tertiary structure of the protein on which the catalytic activity of enzymes depend. For enzymes that are critical for the cell, the mutation will probably result in reduced growth or death of the cell unless the addition of a nutrient to the medium compensates for the reduced enzyme function.

Purine and pyrimidine bases as components of DNA almost certainly exist in solution in more than 1 structural form. The common forms pair specifically with their partners, i.e., A with T and G with C. When an uncommon form, which is in equilibrium with the common one, pairs with a different base, a mutation is produced.

Some chemical mutagens change one base of DNA into another, as nitrous acid converts cytosine to uracil and this changes the base pairing during replication. Other agents modify the bases so the proportion of the form pairing with a different base is increased.

Base analogs are mutagenic because they are incorporated in place of normal bases and then pair more frequently with one of the unexpected partners than the normal base.

Acridine mutations are importantly different from those described above. They have played a critical role in a test of the coding mechanism but mutations have not been produced as readily by acridines in biologic units other than bacteriophage.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Cell Growth & Differentiation
Copyright © 1966 by the American Association for Cancer Research.